Open-label, multiple-dose, uncontrolled trial to evaluate steady-state pharmacokinetics of naloxone in children from 6 to less than 12 years of age with opioid-induced constipation

Trial Profile

Open-label, multiple-dose, uncontrolled trial to evaluate steady-state pharmacokinetics of naloxone in children from 6 to less than 12 years of age with opioid-induced constipation

Recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Sep 2016

At a glance

  • Drugs Naloxone (Primary)
  • Indications Constipation
  • Focus Pharmacokinetics
  • Sponsors Develco Pharma Schweiz
  • Most Recent Events

    • 09 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top